DE602004014629D1 - Chinolinverbindungen und deren verwendungen - Google Patents

Chinolinverbindungen und deren verwendungen

Info

Publication number
DE602004014629D1
DE602004014629D1 DE602004014629T DE602004014629T DE602004014629D1 DE 602004014629 D1 DE602004014629 D1 DE 602004014629D1 DE 602004014629 T DE602004014629 T DE 602004014629T DE 602004014629 T DE602004014629 T DE 602004014629T DE 602004014629 D1 DE602004014629 D1 DE 602004014629D1
Authority
DE
Germany
Prior art keywords
compounds
chinoline
release
methods
receptor signaling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004014629T
Other languages
English (en)
Inventor
Singh Rajinder
Lin Hui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rigel Pharmaceuticals Inc
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Publication of DE602004014629D1 publication Critical patent/DE602004014629D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
DE602004014629T 2003-09-12 2004-09-01 Chinolinverbindungen und deren verwendungen Expired - Fee Related DE602004014629D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50260503P 2003-09-12 2003-09-12
PCT/US2004/028411 WO2005033103A1 (en) 2003-09-12 2004-09-01 Quinoline compounds and their uses

Publications (1)

Publication Number Publication Date
DE602004014629D1 true DE602004014629D1 (de) 2008-08-07

Family

ID=34421502

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004014629T Expired - Fee Related DE602004014629D1 (de) 2003-09-12 2004-09-01 Chinolinverbindungen und deren verwendungen

Country Status (6)

Country Link
US (1) US8008501B2 (de)
EP (1) EP1675850B1 (de)
AT (1) ATE399165T1 (de)
DE (1) DE602004014629D1 (de)
ES (1) ES2308251T3 (de)
WO (1) WO2005033103A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1984894A (zh) * 2004-05-14 2007-06-20 Irm责任有限公司 作为ppar调节剂的化合物和组合物
WO2012154518A1 (en) 2011-05-10 2012-11-15 Merck Sharp & Dohme Corp. Bipyridylaminopyridines as syk inhibitors
CA2834062A1 (en) 2011-05-10 2012-11-15 Merck Sharp & Dohme Corp. Pyridyl aminopyridines as syk inhibitors
BR112013028900A2 (pt) 2011-05-10 2017-01-03 Merck Sharp & Dohe Corp Composto, composição farmacêutica, e, método para o tratamento ou a prevenção de doenças
WO2013052394A1 (en) 2011-10-05 2013-04-11 Merck Sharp & Dohme Corp. 2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
US9006444B2 (en) 2011-10-05 2015-04-14 Merck Sharp & Dohme Corp. Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
EP2763975B1 (de) 2011-10-05 2016-04-06 Merck Sharp & Dohme Corp. 3-pyridyl-carboxamidhaltige milztyrosinkinase-(syk)-hemmer
EP2863914B1 (de) 2012-06-20 2018-10-03 Merck Sharp & Dohme Corp. Pyrazolylderivate als syk-hemmer
US9487504B2 (en) 2012-06-20 2016-11-08 Merck Sharp & Dohme Corp. Imidazolyl analogs as syk inhibitors
US9416111B2 (en) 2012-06-22 2016-08-16 Merck Sharp & Dohme Corp. Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors
EP2863916B1 (de) 2012-06-22 2018-07-18 Merck Sharp & Dohme Corp. Substituierte pyridin-milz-tyrosinkinaseinhibitoren
WO2014031438A2 (en) 2012-08-20 2014-02-27 Merck Sharp & Dohme Corp. SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
EP2900665B1 (de) 2012-09-28 2018-01-03 Merck Sharp & Dohme Corp. Triazolylderivate als syk-hemmer
US9624210B2 (en) 2012-12-12 2017-04-18 Merck Sharp & Dohme Corp. Amino-pyrimidine-containing spleen tyrosine kinase (Syk) inhibitors
EP2934525B1 (de) 2012-12-21 2019-05-08 Merck Sharp & Dohme Corp. Thiazolsubstituierte aminopyridine als milztyrosinkinasehemmer
EP2988749B1 (de) 2013-04-26 2019-08-14 Merck Sharp & Dohme Corp. Thiazolsubstituierte aminopyridine als milztyrosinkinasehemmer
US9745295B2 (en) 2013-04-26 2017-08-29 Merck Sharp & Dohme Corp. Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
WO2015095445A1 (en) 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
WO2015095444A1 (en) 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
EP3082807B1 (de) 2013-12-20 2018-07-04 Merck Sharp & Dohme Corp. Thiazolsubstituierte aminoheteroaryle als milztyrosinkinasehemmer
US9775839B2 (en) 2014-03-13 2017-10-03 Merck Sharp & Dohme Corp. 2-pyrazine carboxamides as spleen tyrosine kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES448386A1 (es) * 1975-06-05 1978-04-16 Hoechst Ag Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
DE3225169A1 (de) 1982-07-06 1984-01-12 Basf Ag, 6700 Ludwigshafen Chinolinderivate, verfahren zu ihrer herstellung, diese enthaltende mikrobizide und ihre verwendung zur bekaempfung von pilzen
DE3621540A1 (de) 1986-06-27 1988-01-07 Basf Ag Chinolinderivate, verfahren zu ihrer herstellung, diese enthaltende mikrobizide und ihre verwendung zur bekaempfung von bakterien und pilzen
WO1994024095A1 (en) 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
JP4245682B2 (ja) * 1997-12-25 2009-03-25 協和発酵キリン株式会社 キノリン誘導体、イソキノリン誘導体、およびシンノリン誘導体、並びに抗炎症剤および抗アレルギー剤

Also Published As

Publication number Publication date
EP1675850A1 (de) 2006-07-05
ES2308251T3 (es) 2008-12-01
US8008501B2 (en) 2011-08-30
EP1675850B1 (de) 2008-06-25
US20050113412A1 (en) 2005-05-26
ATE399165T1 (de) 2008-07-15
WO2005033103A1 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
DE602004014629D1 (de) Chinolinverbindungen und deren verwendungen
ATE524184T1 (de) 2,4-pyrimidindiamin-verbindungen und ihre verwendungszwecke
NL300933I2 (nl) Letermovir
DE502005006149D1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
NO20055741D0 (no) Nye kjemiske forbindelser
MY142988A (en) Novel aminobenzophenone compounds
DK1594833T3 (da) 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme
ATE380188T1 (de) Substituierte chinolone
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
DE602004007672D1 (de) Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
SE0300850D0 (sv) Chemical compounds
ATE524463T1 (de) 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung
SE0200843D0 (sv) Chemical compounds
EA200701584A1 (ru) Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения
NO20053562L (no) Nye aminobenzofenonforbindelser
ATE553088T1 (de) Substituierte chinolone ii
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
CY1115243T1 (el) Ενωσεις 2,4-πυριμιδινοδιαμινης και οι χρησεις τους
DE602006015338D1 (de) Cholinerge enhancer mit verbesserter durchgängigkeit durch die blut-hirn-schranke zur behandlung von krankheiten, die mit kognitiven störungen einhergehen
DE502006008280D1 (de) Imino-oxazolidine und ihre verwendung als antikoagulantien
TW200514564A (en) Mixture from jelly fig and preparation and use thereof
TH82150A (th) น็อนอาเด็พไซเพ็พไทด์ ที่ถูกอะคริเลท

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee